Role of Articular Cartilage and Chondrocyte Changes and Mononuclear Apoptosis in the Pathogenesis and Strategy of Therapy in Polyarticular Juvenile Rheumatoid Arthritis
S. Hawas ,
M.M. Hafez ,
T. EL-Desoky ,
The objective of this research work is to study the changes in articular cartilage and chondrocytes in juvenile rheumatoid arthritis (JRA) and the implication of mononuclear cells apoptosis, proinflammatory cytokines, keratan sulfate (KS) and Transforming Growth Factor B (TGFB) in the pathogenesis of the joints changes. The study included 42 children diagnosed as polyarticular JRA, according to the criteria of the American College of Rheumatology and 50 normal children as control. The following investigations were carried out: histopathology of articular cartilage specimens and chondrocyte culture, assay of IL-1α, IL-1β, TNF-α, IL-1R, TNF-α p55, TNF-α p75 in synovial fluid (SF) and peripheral blood serum (ser), estimation of concentration of keratan sulfate (KS), transforming growth factor B (TGFB), CD95 (sFas) and assessment of apoptotic index of mononuclear cells, in the synovial fluid and peripheral blood (PB). The results could be summarized as follows: morphological and immunohistochemical changes in the matrix and chondrocytes, increased levels of proinflammatory cytokines and KS and decreased CD95, (sFas), TGFB and apoptotic index of mononuclear cells, in synovial fluid and peripheral blood. The changes are more significant in SF. In conclusion, the delayed mononuclear cell apoptosis and increased secretion of proinflammatory cytokines lead to the morphological and immunchistochemical changes in articular cartilage and chondrocytes, high KS and low TGFB. So far, we can recommend to add to the strategy of therapy, anti-proinflammatory cytokines and injections of TGFB for amelioration of the disease.
to cite this article:
M.F. EL-Batouty, A.EL-Lakkany , S. Hawas , E.EL-Nashar , M.M. Hafez , T. EL-Desoky , B. EL-Deek and M. Hafez , 2003. Role of Articular Cartilage and Chondrocyte Changes and Mononuclear Apoptosis in the Pathogenesis and Strategy of Therapy in Polyarticular Juvenile Rheumatoid Arthritis. Journal of Medical Sciences, 3: 137-156.
Juvenile rheumatoid arthritis (JRA) is an autoimmune disease characterized by infiltration of lymphocytes and macrophages into the synovium, hyperplasia of the synovial lining and destruction of cartilge and bone (Perlman et al., 2001). Macrophage-like and fibroblast-like synoviocytes comprise the normal synovial lining, which consists of 1-2 cell layers but increases to as much as 10 or more cell layers in active JRA (Firestein, 1996). Synovial macrophages express high levels of collagenase, proinflammatory cytokines, colony-stimulating factor, inhibitory protein 1α and chemoattractant protein 1, which are mediators of inflammation and joint destruction (Feldmann et al., 1996).
Cytokines such as interlukin-1β (IL-1β) and tumour necrosis factor α (TNFα) play a central role in this process because they stimulate the production of proinflammatory mediators and inhibit matrix synthesis (Alaaeddine et al., 2001). Death of articular chondrocytes leading to hypocellular cartilage may be an intrinsic death program caused by extrinsic factors as cytokines (Kuhn and Lotz, 2001). The mechanism of dysregulated hyperplasia of the invasive mononuclears and fibroblasts has been proposed to be due to imbalance between growth and apoptosis (Zhang et al., 2000). One of the important factors regulating cell death in lymphocytes is the cell surface Fas (CD95), a member of TNF receptor family (Scaffidi et al., 1998). Stimulation of Fas receptor on activated lymphocytes can induce apoptosis (Lee and Shactre, 2001). In autoimmune diseases the mononuclears accumulate and attracted from the general circulation and congregate within the joint.
Erosion of articular cartilage is associated with degradation and release of matrix proteoglycans (PG). It was reported that keratan sulfate (KS) which is a component of PG is capable of diffusion into the systemic circulation. On the other hand, transforming growth factor B (TGFB) which is an intriguing modulatory factor counteracts interleukin 1 (IL-1) on cartilage through down regulation of IL-1 receptors (Gouze et al., 2001).
The present work was planned to study the changes in articular cartilage and chondrocytes in polyarticular JRA and the implication of mononuclear cells apoptosis, proinflammatory cytokines, KS and TGFB in the pathogenesis of the joint changes, especially that this approach has not been published before in JRA.
Materials and Methods
The study included 42 children diagnosed as polyarticular juvenile rheumatoid arthritis and 50 normal children as control.
The range of age 4-16 years with mean 8.8 ± 4.16 years, 20 boys and
22 girls. The patients were collected from the Department of Rheumatology, the
Main University Hospital and the Children University Hospital at Mansoura, Egypt.
The patients fulfilled the diagnostic criteria for polyarticular JRA of the
American College of Rheumatology (Brewer et al., 1977). A detailed history
and clinical examination was completed for every individual. Patients were examined
and assessed by the same observers for clinical parameters of joint inflammation.
The summed 28-joint index score described by Prevoo et al. (1993) and
slightly modified by Mangge and Chanenstein (1998) was used. All patients has
active disease defined by the presence of arthritis, CRP and Westergren ESR
The control group
Fifty healthy children with matched age and sex (mean age 10.3 ±
3.6 ys, 22 males and 28 females). The children were hospitalized for surgery
of factures, with no history or joint disease. Permission was taken from the
parEnts for drawing extrablood and aspiration of synovial fluid for all subjects
and specimen from the articular cartilage of the affected knee for the patients
and from only 10 out of the 50 normal non-rheumatoid subjects.
The following investigations were carried out:
Resected fragments of loose articular cartilage were used for histopathology of articular cartilage specimen and chondrocytes culture.
Assay of IL-1α, IL-1β, TNF-α, IL-1R, TNFα-R55 and TNF-αR75, for their mRNA and serum levels in the synovial fluid and peripheral blood.
Estimation of the concentration of keratan sulphate in the synovial fluid and peripheral blood.
Estimation of the concentration of Transforming Growth Facor-B (ng ml-1) in the synovial fluid and peripheral blood.
Estimation of CD95 (sFas) in the synovial fluid and peripheral blood.
Apoptosis of the mononuclear cells in the synovial fluid and peripheral blood.
Histopathology of cartilage and chrondrocytes, before and after culture
A standard arthroscopic examination of the knee was performed through anterolateral
and anteromedial portals using Starz wide angle arthroscope. Articular cartilage
was resected using a 3.5 mm. straight or curved basket forceps. Three litres
of saline were then run through the knee (Insall, 1993).Chondrocytes were isolated
from cartilage by sequential enzymatic digestion and cultured in Eagles
minimum essential medium with Earls salts, 100 units ml-1 penicilline,
100 μg ml-1 streptomycine, 2 ml glutamine and 10% fetal calf
serum. Chondrocytes were then incubated for a further 6 hours with IL-1β
(10 units ml-1), TGFB and NSAIDS (50 μM ml-1) (Attur,
For immunohistochemical analysis, cartilage explants were cultured for 10 days in complete medium. The cartilage explants were then fixed in 2% formaldehyde, embedded in paraffin and cut into sections. A conventional peroxidase staining technique for monoclonal antibodies was used (Johansen et al., 2001).
Measurement of serum levels of IL-1α, IL-1β and TNFα, IL-1R,
TNFα-p55, TNFα-p75: Commercially available ELISA Kits (Research and
Diagnostics Systems U.K) specific for IL-1α, IL-1β, TNFα IL-1R,
TNF-αp55 and TNFα-p75 were used (Yamamura et al., 1993).
Detection of cytokine-mRNA
Dection of IL-1α IL-1β and TNFα messenger RNA (mRNA) was
carried as follows: Isolation of peripheral blood mononuclear cells (PBMC) 10-20
ml of peripheral venous blood was collected into sterile pyrogen-free disposable
syringes anticoagulated with endotoxin-free heparin (10 U ml-1).
PBMC were separated by standard density gradient centrifugation (Ficol Hi Paque
Total RNA was extracted from freshly isolated unstimulated PBMC using an
acid phenol-chloroform extraction method. Quantification of total RNA was performed
spectrophotometrically. Cytokine cDNA of PBMC was obtained by reverse transcriptase
(RT) then amplified by polymerase chain reaction (PCR) using specific primers.
The following commercially available (Clontech Laboratories, Inc, palo Alto,
USA) oligonucleotide 5 and 3 and primer sequences were used:
PCR was carried out in a Thermal Cycler (Perkin Elmer Cetus) for 30 cycles
of denaturation (96oC, 1 min), annealing (60 oC, 45s)
and extension (72 oC, 1min). The amplified gene products were separated
by electrophoresis on 2% agarose gel and visualized by UV light illumination
using ethidium bromide stainning. The amount of cytokine PCR products was graded
as follows: - = no band detected, in the undiluted cDNA: sample; + = band detected
in the undiluted cDNA sample but not in the 1:5 diluted cDNA: ++ = band detected
in the 1:5 diluted cDNA but not in the 1:25 diluted cDNA. (Chomeznski and Sacchi,
1987, Becker et al., 1996).
Estimation of Keratan Sulfate (KS)
Concentration in the synovial fluid and serum
Keratan sulfate epitope was measured with an EL1SA inhibition assay
as described by Hauselmann et al. (1992).
Estimation of Transforming Growth Factor B Concentration in the synovial
fluid and serum
Transformating growth factor-β (TGFB) was estimated by ELISA-inhibition
assay (Van Beuningen et al., 1994).
Detection of apoptotic mononuclear cells in synovial fluid and peripheral
Detection of apoptotic cells by giemsa stain, Acridine Orange stain (AO), Propiduim
Iodide stain (PI) and DNA fragmentation
Cells were obtained from whole EDTA-blood using lymphocyte-separating solution
(Ficoll-Paque; Pharmacia, Uppsala, Sweden) by the method of Boyum (1968). Lymphocytes
were washed twice with sterile PBS pH 7-6.
Culture of lymphocyte
Cells were suspended at 107/mI in RPMI 1640 (GIBCO) containing 25 mM glucose
20 mML-glutamine, 92 um gentamycin 20 μg ml-1 (Walkersvlle MD)
and 25 mM HEPES buffer (pH 7.3: GIBCO). Cells were suspended in sterile PBS
(0.05 MPO4 + 0.15M Nacl, pH7.2). The cell suspension were divided into 4 aliquots
to measure the apoptosis at zero time (base time), then 24, 48 and 72 h, cells
were incubated at 37°C in 5% carbon dioxide. After incubation, cells were
centrifuged (200xg 5min), resuspended in ice-cold PBS and analyzed on a Coulter
Assessment of cell viability:At time zero and then at subsequent times, cells were removed from culture and counted on a haemocytometer. Cell viability was determined by trypan blue dye exclusion test, one volume of trypan blue (0.4% GIBCO) was added to 5 volumes of cells at room temperature for 5 minutes.
Detection of apoptotic cells
Propidium iodide stain
Cells were stained with Hoechst 33342 and propidium iodide (PI) and visualized
using fluorescence microscopy as described by Lee and Shacter (1998). A minimum
of 200 cells were counted per sample and were classified as follows:
||Live cells (normal nuclei, blue chromatin with organized structure)
|| Membrane intact apoptotic cells (bright blue chromatin that is highly
condensed, marginated, or fragmented)
||Membrane permeable apoptotic cells (bright red chromatin, highly condensed
At time zero and at subsequent times, cells were removed from each culture,
fixed in methanol, harvested on slides and slides were stained with May Grunwald
Giemsa and examined by oil immersion light microscope (Wyllie and Morris, 1985).
For assessment of the percntage of cells showing morphology of apoptosis 500
cells/slide were examined for each case at different times (0,24,48 and 72 h).
Lymphocyte were considered apoptotic if they exhibited the highly characteristic
morphological features of chromatin aggregation, nuclear pyknosis and cytoplasmic
vaculation. The apoptotic Lymphocyte percentage at different times was calculated.
Acridine orange stain (AO)
One drop of cell suspension was added to one AO solution (10 μg mI-1
in PBS), mixed gently on a slide and immediately examined with an olympus HB-2
microscope with fluorescence attachment. Green fluorescence was detected between
500 and 535nm cells exhibit bright fluorescent condensed nuclei (intact or fragmented)
were interpreted as apoptotic cells and expressed as a percentage of the total
number viable cells, which exhibited a green, diffusely stained intact nucleus
(Kumagai et al., 1995).
Assessment of apoptotic index
For this analysis in each case the mean number of monocytic cells per field
was registered in 15 randomly chosen fields. The apoptotic bodies were then
counted in a greater number of fields and expressed as percentages monocytic
cells per case (Del Vecchio et al., 1991).
Measurement of sFas
The levels of sFas were determined by the following enzyme linked immunosorbent
assay (ELISA) using two anti-human Fas monoclonal antibodies, DX-2 (IgG1) and
DX-3 (IgG2a), that were generated as described previously by Cifon et al.
(1994). These antibodies react with distinct epitopes in the extracellular domain.
Anti-Fas antibody (DX-3; 10 μg ml-1 in 0.01 m phosphate buffered
saline, pH 7.2 (PBS), was coated onto 96 well microtiter plates (Sumililon multiplate
MS-8496 F, Sumitomo Co, Ltd., Japan) and incubated at 37C for 3 h. Blocking
performed with 1:2 dilution with PBS of Block Ace (Dai Nihon Seiyaku Co, Ltd.,
Japan) at 37°C for 2 h. Then sera were added and incubated at room temperature
for 1 h. After washing five times with 0,05% Tween/PBS, 10 μg ml-1
biotin conjugated anti-Fas antibody (DX-2) in 0.05% tween/PBS containing 5%
mouse serum was added and incubated at room temperature for 1 h. After washing
five times, 1:150 diluted ABC solution (Vectastain ABC kit Elite pK-6100, Vector
Laboratories Inc., Burlingame, CA) was added and incubated at room temperature
for 1h. After washing five more times, O-phenylendiamine (OPD) and 0,03% H2
O2 in citrate buffer (pH 5.0) were added and incubated at room temperature for
30 min. OD490 was measured on an automated plate reader (Model 3550-UV Microplate
Reader, Bio-Red, Hercules, CA) and the levels of sFas were determined by comparison
to the standard curve obtained using recombinant sFas (19, 9.5, 4.75, 2.37,
1.18. 0.59. 0.29 and 0.14 ng ml-1). The lower limit of detection
was 0.59 ng ml-1 (Tokans et al., 1996).
Histopathology before and after culture
The morphologic appearance of normal chondrocytes maintained on tissue culture
medium, shows average sized cells, with large dark nucleus and normal cytoplasmic
to nucleus ratio (Fig. 1 and 2). On the
other hand, the morphologic appearance of the chondrocytes taken from patients
with JRA and maintained on tissue culture medium show pale nucleus, marked decrease
of cytoplasm to nucleus ratio and decrease of cells size (Fig.
3). After treatment of these chondrocytes in the culture medium with nonsteroidal
anti inflammatory drugs (NSAIDS) 50 μM ml-1 and TGFB for a further
6 hours the chondrocytes showed improvement of the above mentioned appearance
and became near normal (Fig. 4).
Light microscopy of normal cartilage explants cultured for 7 days showed that
the surface is smooth, large number of chondrocytes are embedded in the cartilage
matrix surrounded by metachromatic material. The cartilage explants from patients
with JRA and cultured for 7 days showed reduction in stainable proteoglycans,
fibrillation, fissuring, chondrocytes necrosis (ghosting), sometimes clonning
with loss of cartilage and matrix is depleted of metachromatic material. On
the other hand articular cartilage explants cultured for seven days with treatment
using NSA1DS (50 μM ml-1) showed attempts of repair, focal proliferation
surrounded by intense metachromatic material indicating increased proteoglycan
By immunostaining, the cartilage specimens from patients with JRA showed identified IL-1 at the surface as well as in clefts, fissures and the matrix of the superficial zone of the cartilage. After treatment in culture with NSA1DS, IL-1 was not present (Fig. 9 and 10).
Immunohistochemical localization of TGFB in articular cartilage of the patients with JRA was done using anti-TGFB antibody. Without treatment there was negative stain (Fig. 11) and after invitro treatment with NSA1DS TGFB was positively stained in the cytoplasm of the chondrocytes (Fig. 12).
The results of the concentration of the proinflammatory cytokines IL-1α,IL-1β,
TNFα and receptors IL-R, TNFα-p55,TNFα-p75 (Table
1) and their mRNA expression (Table 2) in the synovial
fluid and serum of the peripheral blood are similar. The concentrations of all
the cytokines are highly significant increased in patients with JRA in both
synovial fluid and serum compared to control (P < 0.01). Furthermore, the
concentrations are significantly increased in synovial fluid compared to serum
(P < 0.05).
Table 3 presents the concentration of keratan sulphate
in synovial fluid and peripheral blood of patients with JRA and control. The
concentration is very highly significant in patients with JRA compared to control
both in synovial fluid and peripheral blood (>0.001). The concentration is
highly significant increased in synovial fluid compared to peripheral blood
|| Concentration of the IL-1α, IL-1β, TNF-α and
their receptors (P9 ml-1) in synovial fluid (SF) and
|P1 =SF: JRA(vs) control,P2 = Ser: JRA(vs) control, P3 = JRA-SF
(vs) JRA-SerE, P4 = Control SF(vs) Control-Ser.
|| mRNA expression of IL-1α, IL-1β, TNFα, IL-R,
TNFα P55 and P75
|P1=SF: JRA(vs) control,P2 = Ser: JRA(vs) control, P3 = JRA-SF
(vs) JRA-SerE, P4 = Control SF(vs) Control-Ser.
|| Concentration of keratan sulphate (ng ml-1) in
synovial fluid and peripheral blood
||Concentration of Transforming Growth Factor B in the synovial
fluid and peripheral blood (ng ml-1)
Transforming growth factor B
Table 4 illustrates the concentration of transforming
growth factor B in the synovial fluid and peripheral blood. The levels are highly
significant lower in synovial fluid and peripheral blood of JRA compared to
control (P<0.01). No significant difference is present between levels in
the synovial fluid compared to peripheral blood (>0.05).
||Mean ± SD of the concentration of CD95 (sFas) (ng ml-1)
and apoptotic index of synovial (Sf) and peripheral blood (PB) mononuclear
cells after 72 h
|P1: JRA-SF (vs) JRA-PB, P2 : JRA-SF (vs) Control SF,
P3 : JRA-PB (vs) Control PB
||A photomicrograph of chondrocytes of normal subject control
in culture (Hx and E X 400)
||A higher magnification of chondrocytes of normal subject showing
average sized cells with large nucleus and normal cytoplasmic nucleus ratio
(Hx and E X 1000)
||A photomicrograph of chondrocytes of a patient with JRA showing
decrease of cells size and cytoplasmic to nucleus ratio (Hx and E
||A higher magnification of chondrocytes of JRA after treatment
in culture with NSAIDs drugs showing average sized cells with large nucleus
and normal cytoplasmic mucleus ratio similar to chondrocytes of Normal control.
(Hx and E X 100)
||A photomicrograph of joint cartilage of normal subject (control)
(Hx and E X 100)
||A photomicrograph of joint of normal control showing collagen
fibers in capsule and matrix (Massontrichrome X 100)
||A photomicrograph of joint of JRA showing marked decreased
collagen fibers (Massontrichrome X 400)
CD95 and apoptosis
Table 5 shows the mean ± SD of the concentraion
of CD95 and apoptotic index of mononuclear cells from the synovial fluid and
peripheral blood after 72 hours culture. The results by the 3 stains are similar.
The concentration of CD95 and apoptotic index of mononulear cells are lower
in JRA than control and significantly lower in synovial fluid than peripheral
||A photomicrograph of joint of JRA treated with NSAIDS appears
as normal (Massontrichrome X 400)
||A photomicrograph of cartilage of JRA patient in culure before
treatment with NSAIDs showing expression of IL-1 at the cell surface of
chondrocytes and matrix (PAS immunostain X 400)
||A photomicrograph of the cartilage after treatment in culture
with NSAIDs showing no IL-1 at the cell surface of chondrocytes and matrix
(PAS immunostain X 400)
||A photomicrograph of cartilage of JRA in culture with anti
TGFB showing negative reaction (PAS X 400)
||A photomicrograph of cartilage of JRA in culture treated with
NSAIDs and stained with anti TGFM showing positive reaction (PAS X 400)
Degradation of articular cartilage and inflammation of synovium characterize the pathogenesis of arthritis. Proinflammatory cytokines play a central role in the process (Alaaddine et al., 2001). In the present study IL-1α, IL-1β, TNFα and their receptors IL-R, TNF-p55 and TNF-p75 are increased markedy in the synovial fluid and peripheral blood. The more increase in the synovial fluid which is due to homing of the mononuclear cells in the target tissue, secreting the proinflammatory cytokines, which stimulate proinflammatory mediators and proteases and inhibit extracellular matrix synthesis, thus leading to cartilage destruction (Le and Vilcek, 1987). IL-1β and TNFα express the synthesis of proteoglycans, types II and IX collagen (Goldring et al., 1988) and tissue inhibitor of metalloproteinases (Sandy et al., 1992); increase the synthesis of matrix metalloproteinases (MMPS) and plasminogen activator (Compbell et al., 1988) and induce the production of inducible nitric oxide synthase (Stadler et al., 1991).
The combination of IL-1α and the family IL-6 family cytokine oncostatin M (OSM) can synergize to promote cartilage collagen degradation (Cawston et al., 1998). Several studies have implicated cytokine modulation of IL-1R levels on chondrocytes (Pronost et al., 1995) and have proposed that an increase in the receptor of IL-1 levels could augment the IL-1α response, leading to increased proteinase induction (Harvey et al., 1993 and Rowan et al., 2000). In the present study IL-1α and IL-1R are markedly increased in synovial fluid of patients with JRA and inadition the immunohistochemical study of the chondrocytes and cartilage identified IL-1 at the surface as well as in clefts, fissures and the matrix of the superficial zone of the cartilage. In tissue culture, after treatment with NSAIDS, IL-1 was not present. Furthermore, the changes in the chondrocytes we found in the present study as pale nucleus, marked decrease of cytoplasm to nucleus ratio and decrease of cell size, were markedly improved after treatment in the culture with NSAIDS (50 μM ml-1) and TGFB.
Matrix metalloproteinases (MMPs) play key roles in mediating the degradation of connective tissues such as articular cartilage in joints (Billinghurs et al., 1997). The erosions of articular cartilage are associated with degradation and release of matrix proteoglycans (PG), which in case of chronic arthritis can be detected in the synovial fluid of patients (Witter et al., 1987) and experimental animal models (Ratcliffe et al., 1988). These matrix components may be further processed by the synovial milieu (Greiling et al., 1986). PG components and glycosaminoglycans such as keratan sulfate (KS) and hyaluronic acid are capable of diffusion into the systemic circulation (Goldberg et al., 1988). It has been suggested that high serum levels of KS reflect high rates of cartilage turnover and indicate genetic susceptibility to develop chronic arthritis (Sweet et al., 1988). In the present study an interresting finding is the high level of KS in peripheral blood and synovial fluid in patients with JRA compared to normal, which reflects the degradation and release of matrix proteoglycans. This goes in paralellism with the morphological changes of the articular cartilage we found in the present study. The higher concentration of KS in the synovial fluid compared to peripheral blood confirm that the release is from the articular cartilage of the joint.
Attempts to shed light on the potential value of measuring the concentration of joint derived molecules in the blood of patients with rheumatoid arthritis (RA) have led to conflicting results. While the results of 3 studies of serum levels of antigenic keratan sulfate (Ag Ks) have shown that this marker is found at lower levels in patients with RA than in age-matched normal controls, a fourth study has indicated that it is increased in RA patients (Manicourt et al.,1999).
TGFB is a multifunctional cytokine that plays an important role in the regulation of repair and regeneration following tissue injury (Border and Ruoslahti, 1992). It has been shown to induce the synthesis and secretion of extracellular matrix proteins such as transcin, fibronectin and collagens as well as proteoglycans (Haubeck et al., 1995). The degradation of the extracellular matrix is blocked by TGFB which decreases the synthesis of proteases and nduces the increased synthesis of protease inhibitors (Gunther et al., 1994). It is an antagonist of proinflammatory cytokines, as IL-1α, IL-1β and TNF-α and has beneficial effect in inflammatory joint diseases (Haubech et al., 1995).
Cytokines and growth factors are actively involved in the pathogenesis of chronic inflammatory and degenerative joint diseases. In the present study the proinflammatory cytokines and their receptors were found to be significantly high in the synovial fluid and serum and more increased in the former. The results of the mRNA expression and the corresponding circulating IL-1α, IL-1β and TNF-α are in paralellism which indicate unaffected transcriptional or translational processes. Giovine et al. (1986) and Fava et al. (1989) found high levels of IL-1β, TNF-α and IL-8 as well as TGFB1 in the synovial joint diseases. Hafez et al. (2000) found high level of TNF-α in addition to IL-2,IL-4, IL-6, IL-10, IFγ IL-1R, TNF-p55 and TNF-p75in the peripheral blood of patients with JRA.
The inhibitory effect of IL-1β on chondrocyte proteoglycan synthesis is well established (Tyler, 1988). It is also involved in the degradation of proteoglycan and collagens (Gowen et al., 1984, Arner and Pratter, 1989). TNF-α has similar but often weaker effects than those of IL-1β (Dinarells et al., 1986). On the other hand, TNF-α was found to antagonize most of TGFB effects on gene expression (Verrecchia et al., 2000). In addition, TGFB counteracts IL-1 effects on cartilage through down regulation of IL-1 receptors, up regulation of proteoglycan synthesis and release of enzyme inhibitors and IL-1 receptor antagonist (Van Beuningen et al., 1994).
However, the higher concentration of cytokines in the synovial fluid compared to peripheral blood in our patients with JRA, indicate the role of activated T-cells in the pathophysiological events of the disease (Steiner et al., 1999). JRA as an autoimmune disease can result from failure to remove autoimmune cells that arise during immune response to an antigen (Thompson, 1995). The migration of autoreactive lymphocytes and other leukocytes from the blood stream and homing into the target organ, which is the synovium and joint lead to aggregation of these cells and hence secretion of more cytokines leading to pathological effects on cartitage, chondrocytes and synovial membranes. This migration is controlled in part by selective expression and functional regulation of cell adhesion molecules on the cell surface and vascular endothelium cells. Furthermore, the high levels of the cytokines in the peripheral blood is also due to failure to remove the autoimmune cells from the circulation.
In the research, we found low apoptotic index of the mononuclear cells which can lead to their increased numbers and concecutively secretion of of cytokines with high concentration and homing of cells to the joints. We studied the apoptosis of mononuclear cells from the peripheral blood by different methods of stains to endorse the assessment. McGahon et al.. (1995) and Maruyama et al. (2000), reported that the order of apoptotic features such as morphological changes or nuclear condensation is not the same in different types of cells and several methods are needed. The results are the same with the different stains and revealed low counts of apoptotic mononuclear cells.
One of the important factors regulating cell death is the cell surface receptor CD95 (sFas), a member of TNF receptor family (Scaffidi et al., 1998). Stimulation of Fas receptor on activated lymphocytes can induce apoptosis. The death-inducing signal complex is formed by interaction of FADD/MORT-1 activating caspase-8 and caspase-3 which proceed the process of apoptosis (Lee and Shactes, 2001). In the present study the low level of CD95 (sFas) explain the inhibition of apoptosis. However, the high level of TNF-α in our children with JRA can explain the decreased sFas level. Zhang et al. (2000) reported that stimulation of the cells with TNF-α has been shown to generate 2 signals, one that initiates programmed cell death and another that leads to activation of the transcription factor KB (NF-kB), which induces inhibition of apoptosis and promotes the production of proinflammatory factors. TNF-α strongly activates NF-kB through a second class of adaptor protein TNFR-associated factors and this transcriptional factors regulate the expression of antiapoptotic gene products (Beg and Baltimore, 1996, Van Antwerp et al., 1996), such as antiapoptotic members of the Bcl-2 family and the inhibitor of apoptosis c-1AP1 and c-1AP2. Andersen et al. (2000) postulated that there is synergistic effect of TNF-α, IL-1β, IFN-γ in the functional inhibition and induction of cell death.
In conclusion, in patients with JRA there is delayed apoptosis of mononuclear cells due increased level of TNF- α and decreased CD95. This leads to migration of the cells to the joints which are the target organ, infiltation of the synovium and increase secretion of proinflamatory cytokines. This lead to the articular chondrocytes and matrix changes with increased concentration of KS and decreased TGFB which augment the joint changes. So far, we recommend to add to the strategy of therapy, anti-proinflammatory cytokines and injections of TGFB, for amelioration of the disease.
The authors acknowledge Prof. M.M.EL-Battoty Professor of Orthopedic Surgery for doing the arthroscopy and taking the specimens.
1: Alaaeddine, N., T. Olee, S. Hashimoto, L. Creighton and M. Lotz, 2001. Production of the chemokine. RANTS, 44: 1633-1643.
2: Andersen, N.A., C.M. Larsen and T.M. Poulsen, 2000. TNF-α and IFN-γ potentiate IL-1β induced apoptosis of islets of Langerhans. Diabetologica, 43: 1389-1396.
3: Armitage, P., 1996. Statistical Methods in Medical Research. 8th Edn., John Wiley and Sons, New York
4: Arner, E.C. and J.M. Pratter, 1989. Independent effects of interleukin-1 on proteoglycan breakdown proteoglycan synthesis and prostaglandin E2 release from cartilage in organ culture. Arthritis Rheum., 32: 288-297.
5: Attur, M.G., 1998. Autocrine production of IL-1 beta by human osteoarthritis affected cartilage and differential regulation of endogenous niteic oxide, IL-6 prostaglandin E2 and IL-8. Proc Assoc An Physicians, Jan. Feb.
6: Bargatze, R.F., M.A. Jutila and E.C. Butcher, 1995. Distinct roles of L-selectin and integrin α4β and LFA-1 in lymphocyte homing to Peyers patch-HEV in situ. Immunity, 3: 99-108.
7: Becker, A., A. Reith, J. Napivatzki and P. Kadenpach, 1996. A quantiative method of determining initial amounts of DNA by PCR. Anal. Biochem., 237: 204-207.
8: Beg, A.A. and D. Baltimore, 1996. An essential role for NF-kB in preventing TNF-α induced cell death. Science, 274: 782-789.
9: Billinghurs, R.C., L. Dahlberg, M. Lonescu, A. Reiner and R. Bourne, 1997. Enhanced cleavage of type II collagen by collagenases in osteoarthritis articular cartilage. J. Clin. Invest., 99: 1534-1545.
10: Border, W.A. and E. Ruoslahti, 1990. Transforming growing factor Bin disease. J. Clin. Invest., 90: 1-7.
11: Boyum, A., 1968. Isolation of mononulear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest., 97: 77-83.
12: Brewer, E.J., J. Bass, J.T. Baun, C. Cassidy and J. Fink et al., 1977. Current proposed revision of JRA criteria. JRA criteria subcommittee of the diagnostic and therapeutic criteria committee of the American Rheumatism Section of the Arthritis Foundation. Arthritis Rheum., 20: 195-199.
13: Cawston, T.E., V.A. Curry, C.A. Summers, I.M. Clark and G.P. Riley, 1998. The role of oncostain M in animal and human connective tissue collagen turnover and its localization within the rheumatism. Arthritis Rheum., 41: 1760-1771.
14: Chomozynski, P. and N. Sacchi, 1987. Single step method of RNA isolation by acid guaninidium thiocyanateBphenolBchloroform extraction. Anal. Biochem., 162: 156-159.
15: Compbell, K., D.S. Piccoli, D.M. Butler, D.K. Singleton and J.A. Hamilton, 1988. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes. Biochim. Bioplys Acta., 967: 183-194.
Direct Link |
16: Cifone, M.G., R.D. Maria, P. Ronchaidi, M.R. Rippo and M. Azuma et al., 1994. Apoptotic signaling through CD95 (Fas/Apo.1) activates an acidic sphingomyelinase. J. Exp. Med., 180: 1547-1552.
Direct Link |
17: Vecchio, M.T.D., L. Leoncini, K. Buerk, R. Kraft and T. Megha et al., 1991. Diffuse erythrocytic and/or centroblastic malignant non-Hodgkins lymphomas comparison of mitotic and pyknotic (apoptotic) indices. Int. J. Cancer, 47: 38-43.
18: Dinarells, C.A., J.G. Cannon, S.M. Walff, H.A. Bernheim and B. Beutler et al., 1986. Tumor necrosis factor is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med., 163: 1433-1450.
Direct Link |
19: Fava, R.A., N.J. Olsen, J.K. Oja, H. Moses and T. Pincus, 1989. Active and latent forms of transforming growth factor B activity in synovial effusions. J. Exp. Med., 169: 291-296.
20: Feldmann, M., F.M. Brennan and R.N. Maini, 1996. Role of cytokines in rheumatoid arthritis. Ann. Rev. Immunol., 14: 397-440.
CrossRef | Direct Link |
21: Firestein, G.S., 1996. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum., 39: 1781-1790.
22: Giovine, F., J. Manson, G. Nuki and G. Duff, 1986. The presence of tumour necrosis factor activity in synovial exudate fluids from patients with OA and RA. Br. J. Rheumatol., 85: 108-112.
23: Goldberg, R.L., M.E. Lenz and M.A. Thonar, 1988. Levels of plasma hyaluronate in osteoarthritis and rheumatoid arthritis. Trans. Orthop. Res. Sec., 13: 491-491.
24: Goldring, M.B., J. Birkhead, I.J. Sandell, T.S.M. Kimura, 1988. Interleukin-1 suppresses expression of cartilage specific type II and IX collagens in human chondrocytes. J. Clin. Invest., 82: 2026-2037.
25: Gouze, J., K. Bordj, S. Gulberti, B. Terlain, P. Netter and M. Quzzine, 2001. Interleukin-1β Down-Regulates the expression of Glucuronosyl-transferase 1. Arthritis Rheum., 44: 351-360.
Direct Link |
26: Gowen, M., D.D. Wood, E.J. Ihric, M.K.B. Mc Guire and R.G.G. Russell, 1984. Stimulation by human interleukin-1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not human osteoblasts in vitro. Biochem. Biophys Acta, 797: 186-193.
27: Greiling, H., K. Kleesiek and R. Reinatols, 1986. Interactions of Synovial Cells and Synovial Fluid with Cartilage. In: Articular Cartilage Biochemistry, Kuettner, K. and R. Schleyerbach (Eds.). Raven Press, New York
28: Gunther, M., H. Haubeck, J. Blaser, S. Bender and I. Gutgemann et al., 1994. Transforming growth factor B1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum., 37: 395-405.
29: Hafez, M., S. Hawas, M.F.E. Batouty, Z.E. Morsy and A. Shaltout et al., 2000. Genes expression and circulating cytokines in juvenile rheumatoid arthritis. Egypt. J. Pediatrics, 17: 627-650.
30: Harvey, A.K., S.T. Stach and S. Chandrasekha, 1993. Differential modulation of degenarative and repair responses of IL-1 treated chondrocytes by platelet derived growth factor. Biochem. J., 292: 129-136.
Direct Link |
31: Haubeck, H., R. Kock, D.C. Fischer, E.V. Leur, K. Hoffmeister and H. Greiling, 1995. Transforming growth factor B1 a major stimulator of hyaluronan synthesis in human synovial lining cells. Arthritis Rheum., 18: 669-677.
32: Hauselmann, H.J., M.B. Aydelotte, B.L. Schumacher and S.H. Gitelis, 1992. Symthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in akginate leads. Matrix, 12: 116-129.
33: Insall, J.N., 1993. Surgery of the Knee. 2nd Edn., Churchill Livingstone, USA., pp: 179
34: Johansen, J.S., T. Olee, P.A. Price, S. Hashinoto, R.L. Ochs and M. Lotz, 2001. Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum., 44: 826-837.
35: Kuhn, K. and M. Lotz, 2001. Regulation of CD95 (Fas/APO.1) induced apoptosis in human chondrocytes. Arthritis Rheum., 44: 1644-1653.
36: Kumagai, M.E. and M.C.B. Smith, 1995. CD38 suppressor human B lymphopoiesis. J. Exp. Med., 181: 1101-1110.
37: Le, J. and J. Vilcek, 1987. Tumor necrosis factor and IL-1 cytokines with multiple overlapping biological activities. Lab. Invest., 56: 234-248.
38: Lee, Y.J. and E. Shacter, 1999. Oxidative stress inhibits apoptosis in human lymphoma cells. J. Biol. Chem., 274: 19792-19798.
39: Lee, Y. and E. Shacter, 2001. Fas aggregation does not correlate with fas-mediated apoptosis. J. Immunol., 167: 82-89.
Direct Link |
40: Manicourt, D., P. Poilvache, A. Nzeusseu, M.E. Lenz and E.J. Thoran, 1999. Serum levels of hyaluronan antigenic keratan sulfate, matrix metalloproteinase 3 and tissue inhibitor of metalloproteinase 1 in rheumatoid arthritis. Arthritis Rheum., 42: 1861-1869.
Direct Link |
41: Mangge, H. and S. Chenenstein, 1998. Serum Cytokines in juvenile rheumatoid arthritis correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum., 38: 211-220.
42: Maruyama, W., I. Shinji and T. Sato, 2000. Morphological changes in the nucleus and actin cytoskeleton in the process of Fasinduced apoptosis in Jurkat T cells. Histochem. J., 32: 495-503.
43: Mc Gahon, A. J., S.J. Martin, R.P. Bissonnette, A. Mahbouli, Y. Shi and D.R. Green, 1995. The end of t he cell line: methods for the study of apoptosis in vitro. Method Cell. Biol., 46: 153-185.
44: Perlman, H., L.J. Pagliari, L. Hongtae, A. E. Koch and R.M. Pope, 2001. Rheumatoid arthritis synovial macrophages express the fas associated death domain-like IL-1β converting enzyme. Arthritis Rheum., 44: 21-30.
Direct Link |
45: Prevoo M.L.L., P.L. van Riel, M.H. Van Rijsivijk, H.H. Kuper and L.B.A.V. Putle, 1993. Validity and reliability of point indices a longitudinal study in patients with recent onset rheumatoid arthritis. Br. J. Rheumatol., 32: 589-594.
Direct Link |
46: Pronost, S., N. Segond, M. Macro, F. Redini and H. Penfornis, 1995. Modulation of IL-1 receptor expression by transforming growth factor-beta in cultured rabbit articular chondrocytes. Osteoarthritis Cartilage, 3: 147-155.
47: Ratcliffe, A., M. Doherty, R.N. Maini, M. Billingham and E.R. Pettipher, 1988. Raised levels of cartilage componets are found in synovial fluid in early and acute but rarely in chronic disease. Trans. 13: 487-487.
48: Rowan, A.D., P.J.T. Koshy, W.D. Shingleton, B.A.Degnan and J.K. Heath et al., 2000. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage ceollagen breakdown. Arthritis Rheum., 44: 1620-1632.
49: Sandy, J.D., C.R. Flammery, P.J. Neame and L.S. Lohmander, 1992. The structure of aggfrecan fragments in human synovial fluid. J. Clin. Invest., 89: 1512-1516.
50: Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen and M.E. Peter, 1998. Two CD95 (APO-1/Fas) signally pathway. Eur. Mol. Biol. Organ. J., 17: 1675-1675.
51: Stadlerm, J., T.R. Billiar, R.D. Curran and L.A. Mclntyre, 1991. Articular chrondrocyte synthesize nitric oxide in response to cytokines and lipopolysaccharide. J. Immunol., 147: 3915-3920.
Direct Link |
52: Steiner, G., M. Tohidast, G. Witzmann, M. Vesely, A. Gal, M. Kunaver and J.S. Smolen, 1999. Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology, 18: 202-213.
Direct Link |
53: Sweet, M.B.E., A. Coelho and C.M. Schnitzler, 1998. Serum keratan sulphate levels in osteosithritis patients. Arthritis Rheum., 31: 648-652.
54: Thompson, C.B., 1995. Apoptosis in the pathogenesis and treatment of disease. Science, 267: 1456-1462.
55: Tokans, Y., S. Miyake, N. Kayagaki, K. Nosawa and S. Morimoto et al., 1996. Soluble Fas-Molecule in the serum of patients with systemic lupus erythematosi. J. Clin. Immunol., 16: 261-265.
56: Tyler, J., 1988. The Influence of Interleukin-1 and Insulin-Like Growth Factor on the Integrity of Cartilage Matrix. Elsevier, Amesterdam
57: Yamamura, M.R, L. Modulin, I.D. Ohmen and R.L. Moy, 1993. Local expression of antiniflammatory cytokines in cancer. J. Clin. Invest., 91: 1005-1010.
58: Van Beuningen, H.M., P.M. van derkraan and O.J. Arntz, 1994. TGFB1 stimulates articular chondrocyte proteoglycan symthesis and induces osteophyte formation in the murine knee joint. Lab. Invest., 71: 279-290.
59: Van Antwerp, D.J., S.J. Martin, T. Kafrin, D.R. Green and I.M. Verma, 1996. Suppressor of TNF-α-induced apoptosis by NF-k B. Science, 275: 1058-1064.
60: Verrecchia, F., M. Pessah, A. Azeddine and A. Mauviel, 2000. Tumor necrosis Factor α inhibits transforming growth factor-B smad signaling in human dermal fibroblasts via AP-1 activation. J. Biol. Chem., 275: 30226-30231.
61: Witter, J., P.J. Roughley, C. Webber, N. Roberts and A.R. Poole, 1987. The immunologic detection and charactesization of cartilage proteoglycan degradation products in synovial fluid of patients with arthritis. Arthritis Rheum., 30: 519-529.
62: Wyllie, A.H. and A. Morris, 1985. Hormone induced cell death publication and properties of the monocytes undergoing apoptosis after glucocortoid treatment. Am. J. Pathol., 109: 78-87.
63: Zhang, H.N., L. Bibao, P. Yang, T. Zhou and J.D. Mountz, 2000. Gene therapy that inhibits nuclear translocation of nuclear factor KB results in TNF-α induced apoptosis of human synovial fibroblasts. Arthritis Rheum., 43: 1094-1105.